Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Campean (Vienna, Austria), R. Sadushi-Kolici (Vienna, Austria), H. Beckmann (Vienna, Austria), I. Shafran (Vienna, Austria), N. Skoro Sajer (Vienna, Austria), I. Lang (Vienna, Austria). Iron Deficiency in Chronic Thromboembolic Pulmonary Hypertension. 1443

Member's Comments

No comment yet.

Related content which might interest you: Chronic Thromboembolic Pulmonary Hypertension related to ICD Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension Year: 2018 Interventional Treatment in Chronic Thromboembolic Pulmonary Hypertension with Microvasculopathy Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Treatment of Chronic Thromboembolic Pulmonary Hypertension: A new approach Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension Year: 2018 Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Sleep Disordered Breathing (SDB) and Chronic Thromboembolic Pulmonary Hypertension: the Effects of Pulmonary Endoarterectomy Source: International Congress 2017 – CPAP therapy Year: 2017 Pulmonary Hypertension Source: Eur Respir Rev 2009; 18: 193-194 Year: 2009 Pulmonary Hypertension Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies. Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension Year: 2021 Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Dismantling the Obesity Paradox in Acute Pulmonary Embolism Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Pulmonary Hypertension in Childhood Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Pulmonary Hypertension in Hemodialysis Patients Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018